[ET Net News Agency, 21 December 2023] CSTONE PHARMA-B (02616) fell 9.7% to HK$2.23,
dipping below the 50-D SMA of HK$2.236.
It hits an intra-day low of HK$2.22, and an intra-day high of HK$2.56. The total shares
traded was 6.1 million, with a value of HK$14.41m. The active buy/sell ratio is 20:80,
with net selling turnover of HK$8.09m. CHINA INV INFO accounts for greatest net responsive
buying turnover of HK$2.63m, with volume weighted average price of HK$2.341. GUOTAI JUNAN
SEC (HK) accounts for greatest net responsive selling turnover of HK$803,243, with volume
weighted average price of HK$2.366. The stock has fallen a combined 14.9% over the past 2
consecutive trading days.

Basic Information
=================

--------------------------------
Nominal 2.230 % Chg -9.72%
High 2.560 Low 2.220
Shares Tr 6.1m Turnover 14.41m
10-D SMA 2.509 %H.V 92.645
20-D SMA 2.367 VWAP 2.364
50-D SMA 2.236 RSI14 44.929
--------------------------------
Status: Dipping below the 50-D SMA, active buy/sell ratio is 20:80, with net selling
turnover of HK$8.09m, falling a combined 14.9% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
CSTONE PHARMA-B (02616) 2.23 -9.72
HUTCHMED (00013) 25.55 -5.89
GENSCRIPT BIO (01548) 19.56 -2.69
INNOVENT BIO (01801) 39.15 -2.85
EVEREST MED-B (01952) 18.88 +1.07
WUXI BIO (02269) 28.25 -1.57
BEIGENE (06160) 103.00 -6.36
SCICLONE PHARMA (06600) 13.50 -3.57
ZAI LAB (09688) 20.40 -12.45
AKESO (09926) 42.45 -2.41
-----------------------------------------------
(ed)